Biologics for severe asthma: the next frontier in India

a adăugat un sunet Sağlıklı Yaşam

2026-04-09 11:18:20 -

For most asthma patients, inhaled steroids and bronchodilators work. But 5‑10% have severe, uncontrolled asthma despite maximum therapy. Enter biologics — monoclonal antibodies that block specific inflammatory pathways. The India respiratory drugs market forecast predicts that biologics will be a major growth driver in the next decade, as patents expire and local...

0 Commentarii 0 Distribuiri 40 Views 0 previzualizare